• TRADE NAMES: Alti-Pindolol; Apo-Pindol; Barbloc; Durapindol; Gen-Pindolol; Nonspi; Pinbetol; Pinden; Syn-Pindol; Visken (Novartis); Vypen
  • INDICATIONS: Hypertension
  • CLASS: Adrenergic beta-receptor antagonist
  • HALF-LIFE: 3–4 hours

Cutaneous side effects of beta-receptor blockers are clinically polymorphous. They apparently appear after several months of continuous therapy.

Please login to view the rest of this drug profile.

Page last updated 08/08/2024

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric